Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.37 USD | -4.44% | -4.44% | +7.24% |
Apr. 25 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
Apr. 25 | Sector Update: Health Care | MT |
Financials (USD)
Sales 2024 * | 201M | Sales 2025 * | 232M | Capitalization | 906M |
---|---|---|---|---|---|
Net income 2024 * | -161M | Net income 2025 * | -69M | EV / Sales 2024 * | 4.51 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.9 x |
P/E ratio 2024 * |
-5.51
x | P/E ratio 2025 * |
-13.2
x | Employees | 537 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.53% |
Latest transcript on Standard BioTools Inc.
1 day | -4.44% | ||
1 week | -4.44% | ||
Current month | -4.44% | ||
1 month | -13.50% | ||
6 months | +19.10% | ||
Current year | +7.24% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Egholm
CEO | Chief Executive Officer | 61 | 22-04-03 |
Jeffrey Black
DFI | Director of Finance/CFO | 55 | 23-05-14 |
Shane Bowen
CTO | Chief Tech/Sci/R&D Officer | - | Jan. 04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 22-03-31 | |
Fenel Eloi
BRD | Director/Board Member | 66 | 23-03-14 |
Kathy Hibbs
BRD | Director/Board Member | 60 | Jan. 04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 2.37 | -4.44% | 1,456,415 |
24-05-06 | 2.48 | -1.20% | 1,847,856 |
24-05-03 | 2.51 | -0.79% | 1,612,750 |
24-05-02 | 2.53 | -0.39% | 1,725,304 |
24-05-01 | 2.54 | +2.42% | 2,528,580 |
Delayed Quote Nasdaq, May 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.24% | 906M | |
+7.93% | 219B | |
+7.53% | 184B | |
+15.20% | 138B | |
+27.02% | 108B | |
-1.14% | 62.54B | |
+7.23% | 52.22B | |
+12.58% | 51.73B | |
+1.61% | 41.4B | |
+5.32% | 37.17B |
- Stock Market
- Equities
- LAB Stock